Skip to content

Calcitonin-salmon studies: 133 papers with results

Page 2 of 3

Calcitonin-salmon has 1,643 linked papers. PepBank read up to 120 of the most-cited studies that gave it to people, up to 20 other studies, and the main trials.

  1. A double-blind, placebo-controlled, dose-finding trial of intermittent nasal salmon calcitonin for prevention of postmenopausal lumbar spine bone loss.

    Reginster JY · The American journal of medicine · 1995

    Randomized controlled trial · 6 results

  2. Treatment of postmenopausal osteoporosis with continuous daily oral alendronate in comparison with either placebo or intranasal salmon calcitonin.

    Adami S · Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 1993

    Randomized controlled trial · 6 results

  3. The frozen shoulder: diagnosis and treatment. Prospective study of 50 cases of adhesive capsulitis.

    Waldburger M · Clinical rheumatology · 1992

    Randomized controlled trial · 2 results

  4. Effect of different doses of nasal salmon calcitonin on bone mass.

    Thamsborg G · Calcified tissue international · 1991

    Randomized controlled trial · 6 results

  5. Influence of food intake on the bioavailability and efficacy of oral calcitonin.

    Karsdal MA · British journal of clinical pharmacology · 2009

    Randomized controlled trial · 5 results

  6. Nandrolone decanoate and intranasal calcitonin as therapy in established osteoporosis.

    Flicker L · Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 1997

    Randomized controlled trial · 3 results

  7. The treatment of osteoporosis in patients with rheumatoid arthritis receiving glucocorticoids: a comparison of alendronate and intranasal salmon calcitonin.

    Tascioglu F · Rheumatology international · 2005

    Randomized controlled trial · 10 results

  8. Bone loss during gonadotropin releasing hormone agonist treatment and use of nasal calcitonin.

    Roux C · Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 1995

    Randomized controlled trial · 6 results

  9. Effects of Nasal Calcitonin vs. Oral Gabapentin on Pain and Symptoms of Lumbar Spinal Stenosis: A Clinical Trial Study.

    Haddadi K · Clinical medicine insights. Arthritis and musculoskeletal disorders · 2016

    Randomized controlled trial · 2 results

  10. Analgesic effect of intranasal and intramuscular salmon calcitonin in post-menopausal osteoporosis: a double-blind, double-placebo study.

    Pontiroli AE · Aging (Milan, Italy) · 1994

    Randomized controlled trial · 5 results

  11. Salmon calcitonin nasal spray in the prevention of corticosteroid-induced osteoporosis.

    Adachi JD · British journal of rheumatology · 1997

    Non-randomized trial · 2 results

  12. A low cartilage formation and repair endotype predicts radiographic progression of symptomatic knee osteoarthritis.

    Luo Y · Journal of orthopaedics and traumatology : official journal of the Italian Society of Orthopaedics and Traumatology · 2021

    Non-randomized trial · 2 results

  13. Equivalence of nasal spray and subcutaneous formulations of salmon calcitonin.

    Combe B · Calcified tissue international · 1997

    Non-randomized trial · 7 results

  14. Pain relief from nasal salmon calcitonin in osteoporotic vertebral crush fractures. A double blind, placebo-controlled clinical study.

    Lyritis GP · Acta orthopaedica Scandinavica. Supplementum · 1997

    Non-randomized trial · 2 results

  15. Effects of salmon calcitonin on trabecular microarchitecture as determined by magnetic resonance imaging: results from the QUEST study.

    Chesnut CH 3rd · Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2005

    Non-randomized trial · 13 results

  16. Clinical outcome of salmon calcitonin nasal spray treatment in postmenopausal women after total hip arthroplasty.

    Peichl P · Gerontology · 2005

    Non-randomized trial · 5 results

  17. Salmon calcitonin nasal spray treatment for postmenopausal women after hip fracture with total hip arthroplasty.

    Peichl P · Journal of bone and mineral metabolism · 2005

    Non-randomized trial · 4 results

  18. Total and regional bone mineral content and fracture rate in postmenopausal osteoporosis treated with salmon calcitonin: a prospective study.

    Rico H · Calcified tissue international · 1995

    Non-randomized trial · 7 results

  19. Prevention of heterotopic ossification after total hip replacement: a prospective comparison of indomethacin and salmon calcitonin in 60 patients.

    Günal I · Acta orthopaedica Scandinavica · 2001

    Non-randomized trial · 1 result

  20. Analgesic effect of salmon calcitonin in osteoporotic vertebral fractures: a double-blind placebo-controlled clinical study.

    Lyritis GP · Calcified tissue international · 1991

    Non-randomized trial · 3 results

  21. Prevention of bone loss in early nonsurgical and nonosteoporotic high turnover patients with salmon calcitonin: the role of biochemical bone markers in monitoring high turnover patients under calcitonin treatment.

    Lyritis GP · Calcified tissue international · 1995

    Non-randomized trial · 6 results

  22. Is continuous intranasal salmon calcitonin effective in treating axial bone loss in patients with active rheumatoid arthritis receiving low dose glucocorticoid therapy?

    Kotaniemi A · The Journal of rheumatology · 1996

    Non-randomized trial · 8 results

  23. Long-term calcitonin therapy in postmenopausal osteoporosis.

    Gruber HE · Metabolism: clinical and experimental · 1984

    Non-randomized trial · 11 results

  24. Neurogenic claudication and root claudication treated with calcitonin. A double-blind trial.

    Porter RW · Spine · 1988

    Non-randomized trial · 2 results

  25. Calcitonin treatment in reflex sympathetic dystrophy: a preliminary study.

    Hamamci N · The British journal of clinical practice · 1996

    Non-randomized trial · 8 results

  26. Treatment of steroid-induced osteopenia with calcitonin in corticosteroid-dependent asthma. A one-year follow-up study.

    Luengo M · The American review of respiratory disease · 1990

    Non-randomized trial · 6 results

  27. Salmon calcitonin in the therapy of corticoid-induced osteoporosis.

    Ringe JD · European journal of clinical pharmacology · 1987

    Non-randomized trial · 4 results

  28. Fast and effective treatment of malignant hypercalcemia. Combination of suppositories of calcitonin and a single infusion of 3-amino 1-hydroxypropylidene-1-bisphosphonate.

    Thiébaud D · Archives of internal medicine · 1990

    Non-randomized trial · 6 results

  29. Estimation of the effect of salmon calcitonin in established osteoporosis by biochemical bone markers.

    Nielsen NM · Calcified tissue international · 1994

    Non-randomized trial · 4 results

  30. New modes of administration of salmon calcitonin in Paget's disease. Nasal spray and suppository.

    Nagant de Deuxchaisnes C · Clinical orthopaedics and related research · 1987

    Non-randomized trial · 14 results

  31. Calcitonin in phantom limb pain: a double-blind study.

    Jaeger H · Pain · 1992

    Non-randomized trial · 7 results

  32. Analgesic effect of intranasal salmon calcitonin in the treatment of osteoporotic vertebral fractures.

    Pun KK · Clinical therapeutics · 1989

    Non-randomized trial · 3 results

  33. A comparison of the acute effects of subcutaneous and intranasal calcitonin.

    O'Doherty DP · Clinical science (London, England : 1979) · 1990

    Non-randomized trial · 3 results

  34. Nasal calcitonin for treatment of established osteoporosis.

    Overgaard K · Clinical endocrinology · 1989

    Non-randomized trial · 6 results

  35. Dose-response bioactivity and bioavailability of salmon calcitonin in premenopausal and postmenopausal women.

    Overgaard K · The Journal of clinical endocrinology and metabolism · 1991

    Non-randomized trial · 20 results

  36. A comparison of the pulmonary bioavailability of powder and liquid aerosol formulations of salmon calcitonin.

    Clark A · Pharmaceutical research · 2008

    Non-randomized trial · 6 results

  37. Oral salmon calcitonin reduces Lequesne's algofunctional index scores and decreases urinary and serum levels of biomarkers of joint metabolism in knee osteoarthritis.

    Manicourt DH · Arthritis and rheumatism · 2006

    Non-randomized trial · 10 results

  38. The effect of rectal and nasal administration of salmon calcitonin in normal subjects.

    Buclin T · Calcified tissue international · 1987

    Non-randomized trial · 13 results

  39. Effects of calcitonin on basal and thyrotropin-releasing hormone-stimulated prolactin secretion in man.

    Isaac R · The Journal of clinical endocrinology and metabolism · 1980

    Non-randomized trial · 5 results

  40. Use of calcitonin in psychotic agitation or mania.

    Carman JS · Archives of general psychiatry · 1979

    Non-randomized trial · 7 results

  41. Efficacy of intranasal human calcitonin in patients with Paget's disease refractory to salmon calcitonin.

    Muff R · The American journal of medicine · 1990

    Non-randomized trial · 2 results

  42. Treatment of multiple myeloma with nasal spray calcitonin: a histomorphometric and biochemical study.

    Rico H · Bone and mineral · 1990

    Non-randomized trial · 8 results

  43. A placebo controlled crossover trial of subcutaneous salmon calcitonin in the treatment of patients with fibromyalgia.

    Bessette L · Scandinavian journal of rheumatology · 1998

    Non-randomized trial · 3 results

  44. The bioavailability of intranasal salmon calcitonin in healthy volunteers with and without a permeation enhancer.

    Lee WA · Pharmaceutical research · 1994

    Non-randomized trial · 5 results

  45. Treatment of post-menopausal osteoporosis with recombinant human growth hormone and salmon calcitonin: a placebo controlled study.

    Gonnelli S · Clinical endocrinology · 1997

    Non-randomized trial · 3 results

  46. Assessment of the biological effectiveness of nasal synthetic salmon calcitonin (SSCT) by comparison with intramuscular (i.m.) or placebo injection in normal subjects.

    Reginster JY · Bone and mineral · 1987

    Non-randomized trial · 7 results

  47. Nasal administration of salmon calcitonin for prevention of glucocorticoid-induced osteoporosis in children with nephrosis.

    Nishioka T · The Journal of pediatrics · 1991

    Non-randomized trial · 2 results

  48. Morning or evening administration of nasal calcitonin? Effects on biochemical markers of bone turnover.

    Schlemmer A · Bone · 1997

    Non-randomized trial · 5 results

  49. Bioavailability and biological efficacy of a new oral formulation of salmon calcitonin in healthy volunteers.

    Buclin T · Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2002

    Non-randomized trial · 11 results

  50. Plasma kinetics and urinary excretion of exogenous human and salmon calcitonin in man.

    Huwyler R · The American journal of physiology · 1979

    Non-randomized trial · 5 results

How PepBank reports evidence